Biomarkers Market by Product & Application - Global Forecast 2023
Biomarkers Market - Segmented By Product, Type, Application, And Disease Indications - Global Growth, Trends, And Forecast -2023
(EMAILWIRE.COM, October 25, 2018 ) Biomarkers Market By Product (Consumables, Services, & Software), Type (Safety Biomarkers, Efficacy Biomarkers), Application (Diagnostics, Drug Discovery), And Disease Indications (Cancer, Cardiovascular) - Global Market Analysis, Size, Geographic Regional Analysis, Competitive Strategies Analysis And Forecasts (2018 To 2023)
Biomarkers Market Value and Growth Analysis:
Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery and development processes and assessment of disease conditions.
Biomarkers market is expected to reach USD 67.33 billion by 2023 from USD 35.84 billion in 2018 growing at a CAGR of 13.44% during the forecast period 2018-2023
Biomarkers Market Drivers and Restraints:
Increasing research and development spending, rising healthcare expenditure, and growing demand for biomarkers in the diagnostic field are driving the growth of global biomarkers market. In addition, increasing number of low cost of clinical trials in emerging countries, growth initiatives in biomarkers research, increasing growth of information technology, growing demand for drug discovery are further propelling the growth of global biomarkers market. However, the requirement of high investment, improper reimbursement policies, poor regulatory bodies, the high cost of testing procedures, and difficulties in sample collection & storage are the major factors restraining the growth of global biomarkers market.
Biomarkers Market Segment
The Market is segmented based on the product, type, application, and disease indications. Based on product, the market is further sub-segmented as consumables, software, and services. Based on the type, the market is segmented as safety biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is further segmented as diagnostics developments, drug discovery & developments, personalized medicine, and disease risk assessment. Based on disease indications, the market is segmented as cancer, cardiovascular, neurological, and immunological disorders.
Regional Analysis
On the basis of the geographical region, the global biomarkers market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America held the major market share of 39.0% of the global biomarkers market in 2015, whereas Asia-Pacific is estimated to grow at the highest CAGR of 16.20% during the forecast period 2018-2023
Free sample: https://www.marketdataforecast.com/market-reports/biomarkers-market-192/request-sample
Biomarkers Market Competitors Analysis
The key players in global biomarkers industry include Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
Biomarkers Market Value and Growth Analysis:
Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery and development processes and assessment of disease conditions.
Biomarkers market is expected to reach USD 67.33 billion by 2023 from USD 35.84 billion in 2018 growing at a CAGR of 13.44% during the forecast period 2018-2023
Biomarkers Market Drivers and Restraints:
Increasing research and development spending, rising healthcare expenditure, and growing demand for biomarkers in the diagnostic field are driving the growth of global biomarkers market. In addition, increasing number of low cost of clinical trials in emerging countries, growth initiatives in biomarkers research, increasing growth of information technology, growing demand for drug discovery are further propelling the growth of global biomarkers market. However, the requirement of high investment, improper reimbursement policies, poor regulatory bodies, the high cost of testing procedures, and difficulties in sample collection & storage are the major factors restraining the growth of global biomarkers market.
Biomarkers Market Segment
The Market is segmented based on the product, type, application, and disease indications. Based on product, the market is further sub-segmented as consumables, software, and services. Based on the type, the market is segmented as safety biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is further segmented as diagnostics developments, drug discovery & developments, personalized medicine, and disease risk assessment. Based on disease indications, the market is segmented as cancer, cardiovascular, neurological, and immunological disorders.
Regional Analysis
On the basis of the geographical region, the global biomarkers market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America held the major market share of 39.0% of the global biomarkers market in 2015, whereas Asia-Pacific is estimated to grow at the highest CAGR of 16.20% during the forecast period 2018-2023
Free sample: https://www.marketdataforecast.com/market-reports/biomarkers-market-192/request-sample
Biomarkers Market Competitors Analysis
The key players in global biomarkers industry include Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: 18887029626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: 18887029626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results